Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Stock Passes Below 200 Day Moving Average – Should You Sell?

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $33.47 and traded as low as $31.40. Tema Cardiovascular and Metabolics ETF shares last traded at $31.79, with a volume of 12,296 shares trading hands.

Tema Cardiovascular and Metabolics ETF Stock Performance

The firm has a fifty day simple moving average of $33.31 and a 200-day simple moving average of $33.47. The company has a market capitalization of $78.84 million, a PE ratio of 32.89 and a beta of 0.93.

Institutional Trading of Tema Cardiovascular and Metabolics ETF

A hedge fund recently raised its stake in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. raised its stake in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 20.6% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 153,090 shares of the company’s stock after purchasing an additional 26,130 shares during the period. Tema Cardiovascular and Metabolics ETF accounts for approximately 1.4% of Sterling Investment Advisors Ltd.’s holdings, making the stock its 20th biggest holding. Sterling Investment Advisors Ltd. owned 6.03% of Tema Cardiovascular and Metabolics ETF worth $5,104,000 at the end of the most recent reporting period.

Tema Cardiovascular and Metabolics ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.